All blog posts
Total 255 results for
Showing 180 out of 255 results
03 April 2020
COVID-19: Potential legal impact (latest developments) - Pharma (Spain) (03/04/2020)
03 April 2020
UK HC confirms that public interest grounds to refuse or limit an injunction to be used sparingly
02 April 2020
COVID-19: Pressure points: COVID Counterfeits - combating counterfeiting, product replacement, misleading advertising and cyber crime in the current crisis
30 March 2020
What’s next for the UPC project? Our analysis following the German Federal Constitutional Court decision
20 March 2020
COVID-19: People: Collaboration is key in the race to develop a vaccine (Global)
20 March 2020
No plain sailing for the UPC – German Court Upholds Constitutional Challenge
19 March 2020
COVID-19: Potential legal impact (latest developments) – Pharma (Spain)
16 March 2020
COVID-19: Potential legal impact - Pharma (Spain)
16 March 2020
Contractual issues in the Pharmaceutical industry
28 February 2020
UK will not be a part of the UPC – government confirms
24 February 2020
Update on IP rights in the UK during the Brexit transition period and beyond
20 February 2020
European Commission Announces Strategy for Data, Artificial Intelligence and Competition in the Digital Age
Showing 180 out of 255 results
View moreKey contacts
Rebekah Gay
Partner, Head of Intellectual Property, Sydney
Laura Orlando
Managing Partner, Milan Office, Milan
Sue Gilchrist
Consultant, Sydney
Peng Lei
Partner, Herbert Smith Freehills Kramer Kewei Joint Operation, Mainland China and Shanghai
Alexandra Neri
Partner, Paris
Dr Ina vom Feld
Partner, Germany
Sebastian Moore
Partner, Head Intellectual Property, London and Milan
Rachel Montagnon
Knowledge Counsel, London